These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 19912591

  • 1. Ultrastructural alterations in endothelial mitochondria are associated with enhanced nitrotyrosine accumulation and progressive reduction of VEGF expression in sequential protocol renal allograft biopsies with calcineurin inhibitor toxicity.
    Sharma A, Jain S, Gupta R, Banerjee KG, Guleria S, Agarwal SK, Dinda AK.
    Transpl Int; 2010 Apr 01; 23(4):407-16. PubMed ID: 19912591
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies.
    Sharma A, Jain S, Gupta R, Guleria S, Agarwal S, Dinda A.
    Indian J Pathol Microbiol; 2010 Apr 01; 53(4):651-7. PubMed ID: 21045386
    [Abstract] [Full Text] [Related]

  • 3. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N, Torras J, Alperovich G, Cruzado JM, Giménez-Bonafé P, Herrero-Fresneda I, Franquesa Ml, Rama I, Grinyó JM.
    Nephrol Dial Transplant; 2008 Oct 01; 23(10):3111-9. PubMed ID: 18469305
    [Abstract] [Full Text] [Related]

  • 4. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 01; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 5. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
    Singh L, Singh G, Sharma A, Sinha A, Bagga A, Dinda AK.
    Hum Pathol; 2015 Jan 01; 46(1):34-9. PubMed ID: 25449629
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K.
    Nephrol Dial Transplant; 2006 May 01; 21(5):1365-72. PubMed ID: 16449275
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor expression and vascularity in renal allograft biopsies.
    Sarioğlu S, Celik A, Erşen A, Uçer I, Sağlam F, Camsari T, Gülay H.
    Transplant Proc; 2008 May 01; 40(1):178-80. PubMed ID: 18261579
    [Abstract] [Full Text] [Related]

  • 8. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
    Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, van Kan E, Mallat MJ, Florquin S, Surachno J, ten Berge IJ, Bajema IM, de Fijter JW.
    J Am Soc Nephrol; 2006 Sep 01; 17(9):2622-32. PubMed ID: 16899517
    [Abstract] [Full Text] [Related]

  • 9. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK, Weir MR.
    Curr Opin Organ Transplant; 2008 Dec 01; 13(6):614-21. PubMed ID: 19060552
    [Abstract] [Full Text] [Related]

  • 10. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 11. Balancing efficacy and toxicity of kidney transplant immunosuppression.
    Naesens M, Lerut E, Sarwal M, Van Damme B, Vanrenterghem Y, Kuypers DR.
    Transplant Proc; 2009 Oct 27; 41(8):3393-5. PubMed ID: 19857756
    [Abstract] [Full Text] [Related]

  • 12. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies.
    Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM.
    Clin J Am Soc Nephrol; 2007 Jan 27; 2(1):135-42. PubMed ID: 17699397
    [Abstract] [Full Text] [Related]

  • 13. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C.
    Transplant Proc; 2009 Mar 27; 41(2):756-63. PubMed ID: 19328973
    [Abstract] [Full Text] [Related]

  • 14. Stable graft function after reduction of calcineurin inhibitor dosage in paediatric kidney transplant patients.
    Plank C, Benz K, Amann K, Nüsken KD, Dittrich K, Rascher W, Sauerstein K, Stuppy A, Klare B, Dötsch J.
    Nephrol Dial Transplant; 2006 Oct 27; 21(10):2930-7. PubMed ID: 16837512
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE, Savikko J, Rintala JM, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3236-8. PubMed ID: 17175233
    [Abstract] [Full Text] [Related]

  • 16. Role of peritubular capillaries and vascular endothelial growth factor in chronic allograft nephropathy.
    Modelli de Andrade LG, Viero RM, Carvalho MF.
    Transplant Proc; 2009 Nov 27; 41(9):3720-5. PubMed ID: 19917374
    [Abstract] [Full Text] [Related]

  • 17. Platelet CD61 expression in vascular calcineurin inhibitor toxicity of renal allografts.
    Meehan SM, Baliga R, Poduval R, Chang A, Kadambi PV.
    Hum Pathol; 2008 Apr 27; 39(4):550-6. PubMed ID: 18234279
    [Abstract] [Full Text] [Related]

  • 18. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
    Okamoto M, Akioka K, Ushigome H, Higuchi A, Nobori S, Ogino S, Uryuhara K, Kaihara S, Hatta T, Urasaki K, Yoshimura N.
    Clin Transplant; 2006 Apr 27; 20 Suppl 15():16-9. PubMed ID: 16848870
    [Abstract] [Full Text] [Related]

  • 19. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
    Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S.
    J Am Soc Nephrol; 2006 Jan 27; 17(1):305-12. PubMed ID: 16306168
    [Abstract] [Full Text] [Related]

  • 20. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
    Arora-Gupta N, Davies P, McKiernan P, Kelly DA.
    Pediatr Transplant; 2004 Apr 27; 8(2):145-50. PubMed ID: 15049794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.